Ropes & Gray represented medical technology company Imperative Care in closing an oversubscribed $100 million convertible note financing. The transaction was announced on March 17.
Proceeds from the financing will support the continued commercialization of Imperative Care’s stroke and vascular thrombectomy portfolios. Funds will also be used for investment in next-generation and new product development, as well as clinical evidence generation to further demonstrate the impact of these technologies on patient outcomes.
The Ropes & Gray team was led by life sciences transactions partner Ray Grant and included life sciences transactions partners Michael Beauvais and Tara Fisher, finance partner Milap Patel and tax partner Pamela Glazier.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.